52 VCA Transplant Recipient Follow Up_Form.xlsx

Data System for Organ Procurement and Transplantation Network

VCA Transplant Recipient Follow Up_Form.xlsx

VCA Transplant Recipient Follow Up (TRF)

OMB: 0915-0157

Document [xlsx]
Download: xlsx | pdf


Fields to be completed by members





Form Section Field Label Notes

Recipient Information Recipient First Name Display Only - Cascades from Removal Worksheet

Recipient Information Recipient Last Name Display Only - Cascades from Removal Worksheet

Recipient Information Recipient Middle Initial Display Only - Cascades from Removal Worksheet

Recipient Information DOB Display Only - Cascades from Removal Worksheet

Recipient Information SSN Display Only - Cascades from Removal Worksheet

Recipient Information Gender Display Only - Cascades from Removal Worksheet

Recipient Information HIC Display Only - Cascades from TRR

Recipient Information Transplant Date Display Only - Cascades from Removal Worksheet

Recipient Information State of Permanent Residence

Recipient Information Permanent zip code

Provider Information Treating Reconstructive Surgeon Name

Provider Information Treating Reconstructive Surgeon NPI#

Provider Information Treating Transplant Physician Name

Provider Information Treating Transplant Physician NPI#

Provider Information Follow-up Care Provided By:

Donor Information UNOS Donor ID # Display Only - Cascades from Removal Worksheet

Donor Information Donor Type Display Only - Cascades from Removal Worksheet

Donor Information OPO Display Only - Cascades from Removal Worksheet

Patient Status Date Last Seen, Retransplanted, or Death

Patient Status Patient Status

Patient Status Primary Cause of Death

Patient Status Primary Cause of Death - Other Specify

Patient Status Has patient been hospitalized since the Last Patient Status Date

Patient Status Number of Hospitalizations

Socio-Demographic Information Working for income

Socio-Demographic Information Working for income - If Yes, indicate the recipient's working status

Socio-Demographic Information Working for income - If No, Not Working Due To

Socio-Demographic Information - Source of Payment Grant funding

Socio-Demographic Information - Source of Payment Institutional funding

Socio-Demographic Information - Source of Payment Primary Source of Payment

Socio-Demographic Information - Source of Payment Primary Source of Payment - Foreign Government, Specify

Socio-Demographic Information - Source of Payment Secondary Source of Payment

Functional Status Cognitive Development

Functional Status Motor Development

Functional Status Psychosocial consult performed

Functional Status - SF-36 score - Physical Health Physical Functioning (PF) score

Functional Status - SF-36 score - Physical Health Role-Physical (RP) score

Functional Status - SF-36 score - Physical Health Bodily Pain (BP) score

Functional Status - SF-36 score - Physical Health General Health (GH) score

Functional Status - SF-36 score - Mental Health Vitality (VT) score

Functional Status - SF-36 score - Mental Health Social Functioning (SF) score

Functional Status - SF-36 score - Mental Health Role-Emotional (RE) score

Functional Status - SF-36 score - Mental Health Mental Heath (MH) score

Functional Status - Upper Limb DASH Score

Functional Status - Upper Limb Carroll Test Score - Left

Functional Status - Upper Limb Carroll Test Score - Right

Functional Status - Upper Limb Sensibility Test - Semmes Weinstein - Left

Functional Status - Upper Limb Sensibility Test - Semmes Weinstein - Right

Functional Status - Craniofacial Olfactory function restored

Functional Status - Craniofacial - Sensory Testing 2 point discrimination (mm)

Functional Status - Craniofacial - Sensory Testing - Hot/cold testing Can feel heat

Functional Status - Craniofacial - Sensory Testing - Hot/cold testing Can feel cold

Functional Status - Craniofacial - Motor function Oral competence

Functional Status - Craniofacial - Motor function Corneal protection

Functional Status - Craniofacial Functional occlusion restored

Functional Status - Craniofacial Decannulation (if the patient had a tracheostomy)

Functional Status - Craniofacial Feeding Tube Removed (if the patient had a feeding tube to start with)

Functional Status - Craniofacial - Speech Intelligibility Tests Speaking rate

Functional Status - Craniofacial - Speech Intelligibility Tests Percent Intelligibility

Clinical Information Height (inches)

Clinical Information Weight (lbs)

Clinical Information BMI (Body Mass Index) Display Only - Calculated

Clinical Information - Noncompliance Immunosuppression

Clinical Information - Noncompliance Rehabilitation

Clinical Information - Noncompliance Level of Activity

Clinical Information - Noncompliance Other

Clinical Information - Noncompliance Other - Other Specify

Clinical Information Graft Status

Clinical Information Date of Graft Failure

Clinical Information - Causes of Graft Failure Acute Rejection

Clinical Information - Causes of Graft Failure Acute Rejection - Banff score

Clinical Information - Causes of Graft Failure Acute Rejection - Visual skin changes

Clinical Information - Causes of Graft Failure Chronic Rejection

Clinical Information - Causes of Graft Failure Chronic Rejection - Visual skin changes

Clinical Information - Causes of Graft Failure Ischemia

Clinical Information - Causes of Graft Failure Sepsis / Infection

Clinical Information - Causes of Graft Failure Trauma

Clinical Information - Causes of Graft Failure Patient requested removal

Clinical Information - Causes of Graft Failure Non-compliance: immunosuppression

Clinical Information - Causes of Graft Failure Non-compliance: rehabilitation

Clinical Information - Causes of Graft Failure Non-compliance: level of activity

Clinical Information - Causes of Graft Failure Other

Clinical Information - Causes of Graft Failure Other - Other Specify

Clinical Information - Most Recent Lab Data Serum Creatinine (mg/dL)

Clinical Information - Most Recent Lab Data Hemoglobin A1c (%)

Clinical Information - Most Recent Lab Data Donor Specific Antibodies (DSA)

Clinical Information Did patient have any acute rejection episodes during the follow-up period

Clinical Information Did patient have any acute rejection episodes during the follow-up period - Number of episodes

Clinical Information {For each episode} Date of acute rejection diagnosis

Clinical Information {For each episode} Acute rejection was treated

Clinical Information {For each episode} Visual skin changes

Clinical Information {For each episode} Biopsy was done to confirm acute rejection

Clinical Information {For each episode} Banff Score

Clinical Information - Complications New onset diabetes

Clinical Information - Complications Metabolic Complications

Clinical Information - Complications Infectious Complications

Clinical Information - Complications Other Complications

Clinical Information - Complications Other Complications - Other Specify

Clinical Information Post Transplant Malignancy

Clinical Information - Post-transplant Malignancy Donor Related

Clinical Information - Post-transplant Malignancy - Donor Related Diagnosis date:

Clinical Information - Post-transplant Malignancy - Donor Related Tumor type

Clinical Information - Post-transplant Malignancy Recurrence of Pre-Tx Tumor

Clinical Information - Post-transplant Malignancy - Recurrence of Pretransplant Malignancy Date of recurrence

Clinical Information - Post-transplant Malignancy - Recurrence of Pretransplant Malignancy Type of pre-existing tumor

Clinical Information - Post-transplant Malignancy - Recurrence of Pretransplant Malignancy Type of pre-existing tumor - Other, Specify

Clinical Information - Post-transplant Malignancy De Novo Solid Tumor

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Diagnosis date

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: Skin: //squamous cell:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: Skin: //basal cell:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: Skin: //melanoma:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Kaposi's sarcoma: cutaneous:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Kaposi's sarcoma: visceral:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Brain:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: Brain: //Other specify:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Renal carcinoma - specify site(s):

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Carcinoma of vulva, perineum or penis, scrotum:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Carcinoma of the uterus:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Ovarian:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Testicular:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Esophagus:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Stomach:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Small intestine:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Pancreas:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Larynx:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Tongue, throat:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Thyroid:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Bladder:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Breast:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Prostate:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Colo-rectal:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Primary hepatic tumor:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Metastatic liver tumor:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Lung:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types://Leukemia:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Sarcomas:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Other cancers:

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Other Cancers: //Site(s):

Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor Tumor Types: //Primary unknown:

Clinical Information - Post-transplant Malignancy De Novo Lymphoproliferative disease and Lymphoma

Clinical Information - Post-transplant Malignancy - Post Transplant Lymphoproliferative Disease and Lymphoma PTLD: //Diagnosis date:

Clinical Information - Post-transplant Malignancy - Post Transplant Lymphoproliferative Disease and Lymphoma PTLD: //Pathology:

Clinical Information - Post-transplant Malignancy - Post Transplant Lymphoproliferative Disease and Lymphoma PTLD: Pathology: //Other Specify:

Treatment Antiviral

Treatment Antibiotic

Treatment Antifungal

Topical Immunosuppressive Medications Immunosuppression medications

Topical Immunosuppressive Medications Immunosuppression medications - Other Specify

Topical Immunosuppressive Medications Previous maintenance indication

Topical Immunosuppressive Medications Current maintenance indication

Topical Immunosuppressive Medications Anti-rejection indication

Non-Topical Immunosuppressive Medications Immunosuppression medications

Non-Topical Immunosuppressive Medications Immunosuppression medications - Other Specify

Non-Topical Immunosuppressive Medications Previous maintenance indication

Non-Topical Immunosuppressive Medications Current maintenance indication

Non-Topical Immunosuppressive Medications Anti-rejection indication









PUBLIC BURDEN STATEMENT:


The private, non-profit Organ Procurement and Transplantation Network (OPTN) collects this information in order to perform the following OPTN functions: to assess whether applicants meet OPTN Bylaw requirements for membership in the OPTN; and to monitor compliance of member organizations with OPTN Obligations. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control number for this information collection is 0915-0157 and it is valid until xx/xx/20xx. This information collection is required to obtain or retain a benefit per 42 CFR §121.11(b)(2). All data collected will be subject to Privacy Act protection (Privacy Act System of Records #09-15-0055). Data collected by the private non-profit OPTN also are well protected by a number of the Contractor’s security features. The Contractor’s security system meets or exceeds the requirements as prescribed by OMB Circular A-130, Appendix III, Security of Federal Automated Information Systems, and the Departments Automated Information Systems Security Program Handbook. The public reporting burden for this collection of information is estimated to average 3 hours per response, including the time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 14N136B, Rockville, Maryland, 20857 or paperwork@hrsa.gov.











File Typeapplication/vnd.openxmlformats-officedocument.spreadsheetml.sheet
File Modified0000-00-00
File Created0000-00-00

© 2024 OMB.report | Privacy Policy